XML 25 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Warrants and Options
Convertible debt
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Warrants and Options
Additional Paid-In Capital
Convertible debt
Accumulated Earnings (Deficit)
Accumulated Other Comprehensive Loss
Balances (in shares) at Dec. 31, 2018       64,185          
Balances at Dec. 31, 2018 $ 220,335     $ 6 $ 402,934     $ (182,600) $ (5)
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock upon exercise of options (in shares)       14          
Issuance of common stock upon exercise of options 25       25        
Issuance of common stock in conjunction with vesting of restricted stock units (in shares)       132          
Stock-based compensation 2,702       2,702        
Shares withheld for payment of employee's withholding tax liability (216)       (216)        
Net income (loss) (14,301)             (14,301)  
Balances (in shares) at Mar. 31, 2019       64,331          
Balances at Mar. 31, 2019 208,545     $ 6 405,445     (196,901) (5)
Balances (in shares) at Dec. 31, 2018       64,185          
Balances at Dec. 31, 2018 220,335     $ 6 402,934     (182,600) (5)
Increase (Decrease) in Stockholders' Equity                  
Net income (loss) (27,906)                
Comprehensive loss (27,906)                
Balances (in shares) at Jun. 30, 2019       64,821          
Balances at Jun. 30, 2019 197,439     $ 6 407,944     (210,506) (5)
Balances (in shares) at Mar. 31, 2019       64,331          
Balances at Mar. 31, 2019 208,545     $ 6 405,445     (196,901) (5)
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock under employee stock purchase plan (in shares)       64          
Issuance of common stock under employee stock purchase plan 158       158        
Issuance of common stock in conjunction with vesting of restricted stock units (in shares)       426          
Stock-based compensation 2,634       2,634        
Shares withheld for payment of employee's withholding tax liability (293)       (293)        
Net income (loss) (13,605)             (13,605)  
Comprehensive loss (13,605)                
Balances (in shares) at Jun. 30, 2019       64,821          
Balances at Jun. 30, 2019 197,439     $ 6 407,944     (210,506) (5)
Balances (in shares) at Dec. 31, 2019       80,888          
Balances at Dec. 31, 2019 57,958     $ 8 457,751     (399,801) 0
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock in conjunction with vesting of restricted stock units (in shares)       434          
Reacquisition of equity component of 2021 Notes and 2024 Notes     $ (16,814)       $ (16,814)    
Stock-based compensation 1,934       1,934        
Shares withheld for payment of employee's withholding tax liability (271)       (271)        
Net income (loss) 41,230             41,230  
Balances (in shares) at Mar. 31, 2020       81,322          
Balances at Mar. 31, 2020 84,037     $ 8 442,600     (358,571) 0
Balances (in shares) at Dec. 31, 2019       80,888          
Balances at Dec. 31, 2019 57,958     $ 8 457,751     (399,801) 0
Increase (Decrease) in Stockholders' Equity                  
Net income (loss) 6,731                
Comprehensive loss 6,731                
Balances (in shares) at Jun. 30, 2020       107,092          
Balances at Jun. 30, 2020 84,978     $ 11 478,037     (393,070) 0
Balances (in shares) at Mar. 31, 2020       81,322          
Balances at Mar. 31, 2020 84,037     $ 8 442,600     (358,571) 0
Increase (Decrease) in Stockholders' Equity                  
Issuance of common stock under employee stock purchase plan (in shares)       76          
Issuance of common stock under employee stock purchase plan 49       49        
Issuance of common stock in conjunction with vesting of restricted stock units (in shares)       215          
Issuance of common stock in conjunction with vesting of restricted stock units 0       0        
Issuance of common stock in conjunction with the Zyla Merger (in shares)       25,479          
Issuance common stock, warrants, and stock options in conjunction with the Zyla Merger 22,931 $ 11,626   $ 3 22,928 $ 11,626      
Reacquisition of equity component of 2021 Notes and 2024 Notes     $ (2,718)       $ (2,718)    
Stock-based compensation 3,593       3,593        
Shares withheld for payment of employee's withholding tax liability (41)       (41)        
Net income (loss) (34,499)             (34,499)  
Comprehensive loss (34,499)             (34,499)  
Balances (in shares) at Jun. 30, 2020       107,092          
Balances at Jun. 30, 2020 $ 84,978     $ 11 $ 478,037     $ (393,070) $ 0